APA (7th ed.) Citation

A, I., VB, K., T, A., O, M., S, T., BM, W., . . . L, A. (2026). Noninvasive optical coherence tomography biomarker for Alport syndrome, COL4-related focal segmental glomerulosclerosis, and COL4 variant interpretation. Kidney international. https://doi.org/10.1016/j.kint.2026.06.029

Chicago Style (17th ed.) Citation

A, Ibrahim, et al. "Noninvasive Optical Coherence Tomography Biomarker for Alport Syndrome, COL4-related Focal Segmental Glomerulosclerosis, and COL4 Variant Interpretation." Kidney International 2026. https://doi.org/10.1016/j.kint.2026.06.029.

MLA (9th ed.) Citation

A, Ibrahim, et al. "Noninvasive Optical Coherence Tomography Biomarker for Alport Syndrome, COL4-related Focal Segmental Glomerulosclerosis, and COL4 Variant Interpretation." Kidney International, 2026, https://doi.org/10.1016/j.kint.2026.06.029.